Profiel
Philippe Mendels-Flandre is the founder of Austral DX, serving as Chief Executive Officer since 2021.
Former positions include General Manager-Emerging Markets at Shire France SAS and Chief Operating Officer at Lysogene SA from 2017 to 2018.
Education includes an undergraduate degree from The Louvain School of Management.
Actieve functies van Philippe Mendels-Flandre
| Bedrijven | Functie | Begin |
|---|---|---|
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Algemeen Directeur | 01-01-2021 |
Eerdere bekende functies van Philippe Mendels-Flandre
| Bedrijven | Functie | Einde |
|---|---|---|
| LYSOGENE | Operationeel Directeur | 15-11-2018 |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Opleiding van Philippe Mendels-Flandre
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lysogene SA
Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
The Louvain School of Management
The Louvain School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AUSTRAL Dx
AUSTRAL Dx Medical SpecialtiesHealth Technology Develops ultrasound-based diagnostic system for lung and cardiac diseases | Health Technology |
















